OBJECTIVE	A clinical study was therefore conducted to determine their relative suitability as OATP1B probes using single oral ( PO ) and intravenous ( IV ) doses of the OATP1B inhibitor rifampicin , accompanied by a comprehensive in vitro assessment of rifampicin inhibitory potential on statin transporters .\